Kidney International - McMaster Experts

publication venue for

GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes. 101:360-368. 2022
Anticoagulation in patients with kidney failure on dialysis: factor XI as a therapeutic target. 100:1199-1207. 2021
Shared decision-making in hemodialysis vascular access practice. 100:799-808. 2021
A prospective cohort study of acute kidney injury and kidney outcomes, cardiovascular events, and death. 99:456-465. 2021
Evaluating multiple living kidney donor candidates simultaneously is more cost-effective than sequentially. 98:1578-1588. 2020
Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. 97:42-61. 2020
The caveolin-1 regulated protein follistatin protects against diabetic kidney disease. 96:1134-1149. 2019
Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. 96:836-849. 2019
Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. 96:37-47. 2019
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. 95:1304-1317. 2019
The Fracture Risk Assessment Tool (FRAX®) predicts fracture risk in patients with chronic kidney disease. 95:447-454. 2019
Hemodialysis vascular access in the elderly—getting it right. 95:38-49. 2019
Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop. 94:1053-1068. 2018
Grams ME, Sang Y, Ballew SH, et al, for the Chronic Kidney Disease Prognosis Consortium. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 2018;93:1442–1451. 94:1025-1026. 2018
The Authors Reply. 92:767-767. 2017
Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference. 92:297-305. 2017
The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation. 91:928-936. 2017
Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes. 91:683-690. 2017
Patients receiving frequent hemodialysis have better health-related quality of life compared to patients receiving conventional hemodialysis. 91:746-754. 2017
Plasmapheresis for the treatment of kidney diseases. 90:974-984. 2016
Application of new acute kidney injury biomarkers in human randomized controlled trials. 89:1372-1379. 2016
Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events. 89:1144-1152. 2016
Recommendations for kidney disease guideline updating: a report by the KDIGO Methods Committee. 89:753-760. 2016
Preservation of residual kidney function in hemodialysis patients: reviving an old concept. 90:262-271. 2016
Treatment frequency and mortality among incident hemodialysis patients in the United States comparing incremental with standard and more frequent dialysis. 90:1071-1079. 2016
Comparison of standard and accelerated initiation of renal replacement therapy in acute kidney injury. 88:897-904. 2015
Perioperative heart-type fatty acid binding protein is associated with acute kidney injury after cardiac surgery. 88:576-583. 2015
Modifiable lifestyle and social factors affect chronic kidney disease in high-risk individuals with type 2 diabetes mellitus. 87:784-791. 2015
Endothelin-1, but not angiotensin II, induces afferent arteriolar myosin diphosphorylation as a potential contributor to prolonged vasoconstriction. 87:370-381. 2015
A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection. 87:182-194. 2015
Reducing hospital readmissions in patients with end-stage kidney disease. 88:1250-1260. 2015
The relationship between estimated sodium and potassium excretion and subsequent renal outcomes. 86:1205-1212. 2014
The three-year incidence of fracture in chronic kidney disease. 86:810-818. 2014
End-stage renal disease in living kidney donors. 86:20-22. 2014
KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient. 85:1303-1309. 2014
Biocompatible peritoneal dialysis solutions: many questions but few answers. 84:864-866. 2013
Nephrologist follow-up improves all-cause mortality of severe acute kidney injury survivors. 83:901-908. 2013
A multinational cohort study of in-center daily hemodialysis and patient survival. 83:300-307. 2013
Oral bisphosphonate use in the elderly is not associated with acute kidney injury. 82:903-908. 2012
The effect of frequent hemodialysis on nutrition and body composition: Frequent Hemodialysis Network Trial. 82:90-99. 2012
Reporting of the estimated glomerular filtration rate decreased creatinine clearance testing. 81:1245-1247. 2012
Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD. 81:1248-1253. 2012
Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients. 81:586-594. 2012
Vascular access surveillance: an ongoing controversy. 81:132-142. 2012
Early postoperative serum cystatin C predicts severe acute kidney injury following pediatric cardiac surgery. 80:655-662. 2011
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. 79:1341-1352. 2011
Prevention and management of catheter-related infection in hemodialysis patients. 79:587-598. 2011
Traditional and non-traditional strategies to optimize catheter function: go with more flow. 78:1218-1231. 2010
The Authors Reply:. 78:112-112. 2010
Nephroprotective drugs from traditionally used Aboriginal medicinal plants. 77:471-472. 2010
Smad3-dependent and -independent pathways are involved in peritoneal membrane injury. 77:319-328. 2010
Results of a randomized controlled trial on statin use in dialysis patients had no influence on statin prescription. 76:1172-1179. 2009
Response to ‘The data on transplantation in Saudi Arabia are complex and require additional framework for interpretation’. 76:914-915. 2009
When laboratories report estimated glomerular filtration rates in addition to serum creatinines, nephrology consults increase. 76:318-323. 2009
Global trends in the rates of living kidney donation. 75:1088-1098. 2009
Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis. 75:542-549. 2009
Development of end stage renal disease following an acute cardiac event. 74:356-363. 2008
Plasma exchange for myeloma kidney: cast(s) away?. 73:1211-1213. 2008
Chronic kidney disease and postoperative mortality: A systematic review and meta-analysis. 73:1069-1081. 2008
Differences in tolerance for health risk to the living donor among potential donors, recipients, and transplant professionals. 73:1159-1166. 2008
Acute kidney injury: Better biomarkers and beyond. 73:801-803. 2008
Critical issues related to real-time fluorescence imaging of renal tissues using confocal microscopy. 73:656-656. 2008
Response to ‘Chronically decreased GFR and cardiovascular risk in living kidney donors’. 73:509-510. 2008
Studying channel and receptor physiology in podocytes. 73:364-364. 2008
Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex. 73:213-219. 2008
Improving on-line information for potential living kidney donors. 71:1062-1070. 2007
Response to ‘Reduced kidney function in living donors’. 71:1077-1077. 2007
When to refer patients with chronic kidney disease for vascular access surgery: Should age be a consideration?. 71:555-561. 2007
Frequent Hemodialysis Network (FHN) randomized trials: Study design. 71:349-359. 2007
Homocysteine induces mesangial cell apoptosis via activation of p38-mitogen-activated protein kinase. 71:304-311. 2007
Lost in publication: Half of all renal practice evidence is published in non-renal journals. 70:1995-2005. 2006
Proteinuria and reduced kidney function in living kidney donors: A systematic review, meta-analysis, and meta-regression. 70:1801-1810. 2006
Central venous catheter outcomes in nocturnal hemodialysis. 70:1348-1354. 2006
Improvements in cognition in patients converting from thrice weekly hemodialysis to nocturnal hemodialysis: A longitudinal pilot study. 70:956-962. 2006
Absence of renal sequelae after childhood Escherichia coli O157:H7 gastroenteritis. 70:807-812. 2006
Reply from the Authors. 68:2914-2914. 2005
Arteriovenous fistula outcomes in the era of the elderly dialysis population. 67:2462-2469. 2005
A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. 67:1500-1508. 2005
Insulin-like growth factors inhibit podocyte apoptosis through the PI3 kinase pathway. 67:1308-1314. 2005
Microalbuminuria three years after recovery from Escherichia coli O157 hemolytic uremic syndrome due to municipal water contamination. 67:1476-1482. 2005
Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease. 66:S59-S62. 2004
Activation of mesangial cell MAPK in responseto homocysteine. 66:733-745. 2004
Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: Results of the HOPE Study. 65:1375-1380. 2004
Estimating the prevalence of renal insufficiency in seniors requiring long-term care. 65:649-653. 2004
Albuminuria and renal insufficiency prevalence guides population screening. 64:760-761. 2003
Albuminuria and renal insufficiency prevalence guides population screening. 64:761-762. 2003
Cardiovascular risk in patients with mild renal insufficiency. 63:S192-S196. 2003
Distinct distribution of specific members of protein 4.1 gene family in the mouse nephron. 63:1321-1337. 2003
Renal insufficiency and the risk of cardiovascular mortality. 62:1474-1474. 2002
Reply from the Authors. 62:1474-1475. 2002
Albuminuria and renal insufficiency prevalence guides population screening: Results from the NHANES III. 61:2165-2175. 2002
Moderate renal insufficiency and the risk of cardiovascular mortality: Results from the NHANES I. 61:1486-1494. 2002
Association between renal insufficiency and malnutrition in older adults: Results from the NHANES III. 60:1867-1874. 2001
Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: A prospective study. 58:2543-2545. 2000
Preservation of glomerular filtration rate on dialysis when adjusted for patient dropout. 57:691-696. 2000
Stretch activation of Jun N-terminal kinase/stress-activated protein kinase in mesangial cells. 58:1431-1439. 2000
Nitric oxide modulates stretch activation of mitogen-activated protein kinases in mesangial cells. 58:1067-1077. 2000
Mesangial cell signaling cascades in response to mechanical strain and glucose. 56:1721-1728. 1999
Activation of mesangial cell signaling cascades in response to mechanical strain. 55:476-485. 1999
Carbamylated hemoglobin and carbamylated plasma protein in hemodialyzed patients. 53:488-495. 1998
Dietary supplementation with L-arginine limits cell proliferation in the remnant glomerulus. 48:1857-1865. 1995
A controlled trial of cyclosporine in patients with progressive membranous nephropathy. 47:1130-1135. 1995
Fish oil in lupus nephritis: Clinical findings and methodological implications. 44:75-86. 1993
Modulation of the secretion of potassium by accompanying anions in humans. 39:1206-1212. 1991
Omega-3 fatty acid dietary supplementation in systemic lupus erythematosus. 36:653-660. 1989
Effects of hemodialysis and hypertonic hemodiafiltration on cardiac function compared. 32:399-407. 1987
Prognosis of adult onset polycystic kidney disease re-evaluated. 26:190-193. 1984
Noninvasive monitoring of renal transplant function by analysis of beta2-microglobulin. 23:767-770. 1983
In vivo platelet activation with in vitro hyperaggregability to arachidonic acid in renal allograft recipients. 23:506-513. 1983
In vivo platelet activation with in vitro hyperaggregability to arachidonic acid in renal allograft recipients.. 23:506-513. 1983
Experimental nephritis associated with plasmodium infection in mice. 16:53-63. 1979
Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference 2022
Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference 2020
Chronic kidney disease and arrhythmias: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference 2018
A Canadian phase II study evaluating the efficacy of rituximab in the management of patients with relapsed/refractory thrombotic thrombocytopenic purpura 2009
Factors that led to the Walkerton tragedy 2009
Post-infectious irritable bowel syndrome following water contamination 2009
Relationship between Escherichia coli O157:H7 and diabetes mellitus 2009
Renal prognosis of toxigenic Escherichia coli infection 2009
Risk of pregnancy-related hypertension within five years of exposure to bacteria-contaminated drinking water 2009
TTP/HUS: observational studies generate hypotheses that lead to randomized controlled trials 2009
How much peritoneal dialysis is required for the maintenance of a good nutritional state? 1996
Flaxseed: A potential treatment for lupus nephritis 1995
MORBIDITY IN CHRONIC-HEMODIALYSIS PATIENTS - A STUDY OF PROGNOSIS 1990
THE PRESYMPTOMATIC DIAGNOSIS OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY-DISEASE (ADPKD) 1990
THE PROGNOSIS OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY-DISEASE - PKD-1 VS PKD2 1990
OMEGA-3 FATTY-ACID DIETARY SUPPLEMENTATION IN LUPUS NEPHRITIS 1989
RANDOMIZED CLINICAL-TRIAL (RCT) COMPARING PERITONITIS RATES AMONG NEW CAPD PATIENTS USING THE Y-SET DISINFECTANT SYSTEM (Y) TO STANDARD SYSTEMS (S) 1989
PERITONITIS IN CAPD PATIENTS-A RANDOMIZED CLINICAL-TRIAL (RCT) OF TRIMETHOPRIM-SULFAMETHOXAZOLE (TMP/SMX) PROPHYLAXIS 1988
REVERSAL OF PROTEINURIA AND REDUCTION OF MORTALITY IN NZB/W F1 LUPUS MICE BY PROSTAGLANDIN-E1 (PGE1), ILOPROST AND A THROMBOXANE SYNTHASE INHIBITOR (TSI) 1988
THE PRIMARY DETERMINANT OF ONE YEAR GRAFT-SURVIVAL OF CADAVER KIDNEY-TRANSPLANTS IS EARLY RENAL-FUNCTION 1988
PROSTAGLANDINS IN EXPERIMENTAL LUPUS NEPHRITIS 1987
REUSE OF DIALYZERS - A MULTIPLE CROSSOVER TRIAL WITH RANDOM ALLOCATION TO TREATMENT ORDER 1987
COMPLICATIONS RELATED TO THE ROUTE OF MINNESOTA ANTILYMPHOBLAST GLOBULIN (MALG) ADMINISTRATION IN RENAL-TRANSPLANT RECIPIENTS 1985
PRE-NATAL DIAGNOSIS OF KIDNEY DISORDERS BY ULTRASOUND 1985
SEQUENTIAL MINNESOTA ANTILYMPHOBLAST GLOBULIN (MALG) AND (CY) THERAPY AFTER CADAVER RENAL-TRANSPLANTATION 1985
ADULT POLYCYSTIC KIDNEY-DISEASE (APKD) - REAPPRAISAL OF PROGNOSIS 1984
CARPAL-TUNNEL SYNDROME IN DIALYSIS PATIENTS 1984
EFFECTIVENESS OF THIAZIDES IN PREVENTING RECURRENT CALCIUM UROLITHIASIS - THE QUALITY OF THE EVIDENCE 1983
BONE FLUORIDE IN RENAL OSTEODYSTROPHY 1982
KIDNEY-STONE ANALYSIS BY INFRARED-SPECTROSCOPY AS A PREDICTOR OF URINE CHEMISTRY 1981
POLYCYSTIC KIDNEY-DISEASE (PKD) AND GENETIC-MARKERS 1981
PLATELET-AGGREGATING IMMUNE-COMPLEXES IN IDIOPATHIC GLOMERULO-NEPHRITIS AND LUPUS NEPHRITIS 1980
UROLITHIASIS (U) - ENVIRONMENTAL AND GENETIC-FACTORS 1979
UROLITHIASIS (U) - ENVIRONMENTAL AND GENETIC FACTORS 1978
HYPERTENSION, HYPERRENINEMIA AND UNILATERAL RENAL-ARTERY OCCLUSION 1977

has subject area

1103 Clinical Sciences (FoR)
Urology & Nephrology (Science Metrix)

Kidney International Journal

Overview

publication venue for

has subject area

Identity

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)